Two Sigma Investments’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,300
Closed -$1.12M 4054
2021
Q4
$1.12M Buy
4,300
+3,300
+330% +$856K ﹤0.01% 2446
2021
Q3
$264K Buy
+1,000
New +$273K ﹤0.01% 3755
2021
Q1
Sell
-2,500
Closed -$531K 4191
2020
Q4
$531K Buy
+2,500
New +$498K ﹤0.01% 2475
2020
Q3
Sell
-3,900
Closed -$749K 3486
2020
Q2
$749K Sell
3,900
-4,100
-51% -$671K ﹤0.01% 1726
2020
Q1
$1.18M Buy
8,000
+5,000
+167% +$796K 0.01% 1300
2019
Q4
$465K Hold
3,000
﹤0.01% 2854
2019
Q3
$405K Buy
+3,000
New +$393K ﹤0.01% 2720

Other funds holding RMD

Two Sigma Investments's RMD Position: Q1 2026 in Review

Two Sigma Investments opened a new position in ResMed (RMD) in Q1 2026: 312,468 shares worth $70.1M. The stake represents 0.06% of the portfolio and ranks #382 among its holdings. This is a return to the name: Two Sigma Investments previously reported a position in RMD as recently as Q4 2023.

Two Sigma Investments first reported a position in RMD in Q2 2013 and has held it in 22 quarters since. The position peaked at $138M in Q3 2023. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Two Sigma Investments held 312,468 shares of ResMed worth $70.1M as of Q1 2026.
  • ResMed was a new Two Sigma Investments position in Q1 2026.
  • ResMed made up 0.06% of Two Sigma Investments's portfolio in Q1 2026, its #382 holding.
  • Two Sigma Investments first reported a position in ResMed in Q2 2013 and has held it in 22 quarters since.
  • Two Sigma Investments's ResMed position peaked at $138M in Q3 2023.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.